)
)
)
We are a commercial stage biopharmaceutical company focused on the development and commercialization of next generation, clinically superior versions of recombinant therapeutic proteins through our ProCellEx® plant cell-based protein expression system
Year Founded
1994
Next catalyst (value inflection) update
Q1 2026: Earning of 2025
Expected time of next catalyst update
Mar-26
City
Hackensack
Country
United States
Company CEO or top company official
Dror Bashan
Development Phase of Primary Product
Phase II
Exchange
NYSE
Lead Product in Development
PRX 115 for uncontrolled Gouat
Therapeutic Area
Orphan/Rare Diseases
Ticker
PLX
Website
http://protalix.com/
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
